CAHP‐210 dialyzer influence on intra‐dialytic vancomycin removal - Lucksiri, Aroonrut; Scott, Meri K.; Mueller, Bruce A.; Hamburger, Richard J.; Sowinski, Kevin M. (Nephrology, dialysis, transplantation, 2002)
Keywords: Adult; Aged; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Anti-Bacterial Agents - blood; Anti-Bacterial Agents - pharmacokinetics; Anti-Bacterial Agents - therapeutic use; Antibacterial agents; antibiotics; Antibiotics. Antiinfectious agents. Antiparasitic agents; biocompatible membrane; Biological and medical sciences; cellulose acetate; cellulose acetate high performance‐210; Cross-Over Studies; cross‐over study; drug removal; Emergency and intensive care: renal failure. Dialysis management; end‐stage renal disease; Equipment Design; Female; glycopeptide; haemodialysis; hemodialyzer; human; Humans; Intensive care medicine; Kidney Failure, Chronic - therapy; Kinetics; Male; Medical sciences; Metabolic Clearance Rate; Middle Aged; pharmacokinetics; Pharmacology. Drug treatments; prospective study; Renal Dialysis - instrumentation; vancomycin; Vancomycin - blood; Vancomycin - pharmacokinetics; Vancomycin - therapeutic use; Human; Kidney disease; Urinary system disease; Peptides; Apheresis; Hemodialysis; Terminal stage; Hemodialyzer; Permeability; Vancomycin; Enzyme immunoassay; Extrarenal dialysis; Dialyzer; Chemotherapy; Treatment; Glycopeptide